Cite
HARVARD Citation
Cho, H. et al. (2017). Targeted Genome Engineering to Control VEGF Expression in Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells: Potential Implications for the Treatment of Myocardial Infarction. Stem cells translational medicine. pp. 1040-1051. [Online].